Latest Blue Owl Capital Holdings LP Stock Portfolio

Blue Owl Capital Holdings LP Performance:

2025 Q4: 10.53%YTD: -3.75%2024: 0.63%

Performance for 2025 Q4 is 10.53%, and YTD is -3.75%, and 2024 is 0.63%.

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

On 2026-02-20, the fund reported it's updated stock portfolio. In the 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $324 Millions as of 31 Dec, 2025.

The top stock holdings of Blue Owl Capital Holdings LP are , , . The fund has invested 9.4% of it's portfolio in ENGENE HOLDINGS INC and 8.8% of portfolio in NUVEEN CHURCHILL DIRECT LEND.

The fund managers got completely rid off EVERCOMMERCE INC (EVCM), DISC MEDICINE INC and MEREO BIOPHARMA GROUP PLC (MREO) stocks. They significantly reduced their stock positions in ROIVANT SCIENCES LTD (ROIV), AQUESTIVE THERAPEUTICS INC (AQST) and PALVELLA THERAPEUTICS INC NE. Blue Owl Capital Holdings LP opened new stock positions in PROCORE TECHNOLOGIES INC (PCOR), MAPLIGHT THERAPEUTICS INC and IMMIX BIOPHARMA INC (IMMX). The fund showed a lot of confidence in some stocks as they added substantially to KALVISTA PHARMACEUTICALS INC (KALV), ELEDON PHARMACEUTICALS INC (ELDN) and STARDUST PWR INC.

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 10.53% in the last quarter. In trailing 12 months, it's portfolio return was -3.75%.

Performance
S&P 500

New Buys

Ticker	$ Bought
procore technologies inc	6,856,760
maplight therapeutics inc	5,744,770
immix biopharma inc	5,158,040
oric pharmaceuticals inc	4,212,700
payoneer global inc	3,978,330
lenz therapeutics inc	2,400,000
janux therapeutics inc	1,380,000
chime finl inc	1,003,930

New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker	% Inc.
kalvista pharmaceuticals inc	188
eledon pharmaceuticals inc	96.95
stardust pwr inc	90.00
brand engagement network inc	63.56
niocorp devs ltd	60.34
imagenebio inc	52.29
compass therapeutics inc	33.76
livewire group inc	25.00

Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker	% Reduced
roivant sciences ltd	-73.36
aquestive therapeutics inc	-58.00
palvella therapeutics inc ne	-57.74
servicetitan inc	-54.26
ultragenyx pharmaceutical in	-49.66
mineralys therapeutics inc	-34.67
nuveen churchill direct lend	-30.66
compass pathways plc	-22.32

Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker	$ Sold
evercommerce inc	-18,274,700
mereo biopharma group plc	-2,575,000
cero therapeutics hldgs inc	-2,992
tango therapeutics inc	-1,003,090
korro bio inc	-5,028,450
disc medicine inc	-6,757,340
arcellx inc	-2,202,170
verona pharma plc	-98.00

Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 46.6% of it's holdings in Healthcare sector.

Sector	%
Healthcare	46.6
Others	36.8
Technology	8.3
Consumer Cyclical	5.3
Industrials	2.6

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 4.3% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
UNALLOCATED	36.8
SMALL-CAP	31.7
MICRO-CAP	23.7
LARGE-CAP	4.3
MID-CAP	3.3

Stocks belong to which Index?

About 40.7% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	59.2
RUSSELL 2000	40.7

Top 5 Winners (%)		%
	engene holdings inc	301.4 %
	roadzen inc	285.7 %
	syntec optics hldgs inc	175.2 %
	stardust pwr inc	103.0 %
	brand engagement network inc	99.0 %

Top 5 Winners ($)		$
CGEM	cullinan therapeutics inc	10.7 M
	engene holdings inc	7.3 M
CMPX	compass therapeutics inc	5.7 M
HLLY	holley inc	4.5 M
ROIV	roivant sciences ltd	4.1 M

Top 5 Losers (%)		%
KPLT	katapult holdings inc	-100.0 %
	shf holdings inc	-85.2 %
	liminatus pharma inc.	-73.0 %
BKSY	blacksky technology inc	-70.4 %
	alpha modus hldgs inc	-60.1 %

Top 5 Losers ($)		$
CNDT	conduent inc	-4.1 M
RARE	ultragenyx pharmaceutical in	-2.2 M
ELDN	eledon pharmaceuticals inc	-1.6 M
	sagimet biosciences inc	-1.2 M
	nuveen churchill direct lend	-1.2 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 80 stocks in it's portfolio. About 61.8% of the portfolio is in top 10 stocks. CNDT proved to be the most loss making stock for the portfolio. CGEM was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

Last Reported on: 20 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACLX	arcellx inc	0.00	0.00	0.00	sold off	-100

ADCT	adc therapeutics sa	0.91	733,568	2,934,270	unchanged	0.00

AQST	aquestive therapeutics inc	1.05	525,000	3,391,500	reduced	-58.00

BAER	bridger aerospace grp hldgs	0.00	25,000	5,000	new

BKSY	blacksky technology inc	0.00	350,000	17,500	unchanged	0.00

CAH	cardinal health inc	0.11	1,718	353,049	unchanged	0.00

CGEM	cullinan therapeutics inc	7.51	2,350,970	24,332,600	reduced	-6.37

CMPS	compass pathways plc	1.00	469,914	3,242,410	reduced	-22.32

CMPX	compass therapeutics inc	5.74	3,466,520	18,615,200	added	33.76

CNDT	conduent inc	2.86	4,822,420	9,259,050	added	8.2

CNTA	centessa pharmaceuticals plc	1.08	139,450	3,487,640	reduced	-17.7

CNTX	context therapeutics inc	3.37	7,432,910	10,926,400	added	0.34

CVEO	civeo corp	2.62	370,530	8,474,020	added	16.74

DAVE	dave inc	0.01	28,750	28,175	unchanged	0.00

DELL	dell technologies inc	2.09	53,848	6,778,390	added	2.89

DRTS	alpha tau medical ltd	0.12	1,166,120	396,480	new

EAST	beeline holdings inc	0.00	129,529	0.00	new

ELDN	eledon pharmaceuticals inc	0.90	1,929,910	2,914,170	added	96.95

EMLD	fold hldgs inc	0.30	856,632	985,451	unchanged	0.00

EPD	enterprise prods partners l	0.31	31,290	1,003,160	unchanged	0.00